MENLO PARK, Calif. (AP) _ Adverum Biotechnologies Inc. (ADVM) on Wednesday reported a loss of $13.8 million in its third quarter.
On a per-share basis, the Menlo Park, California-based company said it had a loss of 32 cents.
The gene therapy company posted revenue of $463,000 in the period.
In the final minutes of trading on Wednesday, the company's shares hit $3. A year ago, they were trading at $2.90.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADVM at https://www.zacks.com/ap/ADVM